Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Parallel-Group, Randomized, 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of 50 mg Of DVS SR In The Treatment Of Peri- And Postmenopausal Women With Major Depressive Disorder

NCT01121484 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT01121484
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01121484 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Parallel-Group, Randomized, 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of 50 mg Of DVS SR In The Treatment Of Peri- And Postmenopausal Women With Major Depressive Disorder
Lead sponsor
Pfizer
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2010
Completion date
June 30, 2011
Enrollment
439 (actual)
Sites
44

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder